Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

574 ARTÍCULOS , VIENDO DEL 106 AL 120

Repurposing Licensed Drugs for Use Against Alzheimer's Disease

Norins LC.

J Alzheimers Dis. 2021;81(3):921-932. doi: 10.3233/JAD-210080.

Structure, Function and Modulation of Striatal-enriched Protein Tyrosine Phosphatase (STEP)

Liang X, Hou X, Fang H.

Curr Med Chem. 2021;28(37):7714-7728. doi: 10.2174/0929867328666210412123304.

Cerebrovascular Pathology and Responsiveness to Treatment in Alzheimer's Disease: A Systematic Review

Bentham C, De Marco M, Venneri A.

Curr Alzheimer Res. 2021;18(2):103-124. doi: 10.2174/1567205018666210414121227.

Serotonin 2 Receptors, Agomelatine, and Behavioral and Psychological Symptoms of Dementia in Alzheimer's Disease

Li HH, Yao XY, Tao S, Sun X, Li PP, Li XX, Liu ZL, Ren C.

Behav Neurol. 2021 Mar 31;2021:5533827. doi: 10.1155/2021/5533827. eCollection 2021.

Development of grape polyphenols as multi-targeting strategies for Alzheimer's disease

El Gaamouch F, Liu K, Lin HY, Wu C, Wang J.

Neurochem Int. 2021 Jul;147:105046. doi: 10.1016/j.neuint.2021.105046. Epub 2021 Apr 16.

Effect of Sodium Benzoate on Cognitive Function Among Patients With Behavioral and Psychological Symptoms of Dementia: Secondary Analysis of a Randomized Clinical Trial

Lin CH, Chen PK, Wang SH, Lane HY.

JAMA Netw Open. 2021 Apr 1;4(4):e216156. doi: 10.1001/jamanetworkopen.2021.6156.

Endosomal-lysosomal dysfunctions in Alzheimer's disease: Pathogenesis and therapeutic interventions

Lai SSM, Ng KY, Koh RY, Chok KC, Chye SM.

Metab Brain Dis. 2021 Aug;36(6):1087-1100. doi: 10.1007/s11011-021-00737-0. Epub 2021 Apr 21.

Current Strategies for Modulating Aβ Aggregation with Multifunctional Agents

Du Z, Li M, Ren J, Qu X.

Acc Chem Res. 2021 May 4;54(9):2172-2184. doi: 10.1021/acs.accounts.1c00055. Epub 2021 Apr 21.

Role of Natural Plant Products Against Alzheimer's Disease

Varshney H, Siddique YH.

CNS Neurol Disord Drug Targets. 2021;20(10):904-941. doi: 10.2174/1871527320666210420135437.

Essential Oils in Experimental Models of Neuropsychiatric Disorders: A Systematic Review

Fernandes LCB, Costa IM, Freire MAM, Lima FOV, Neta FI, de Souza Lucena EE, Alves RD, Cavalcanti JRLP, Pinheiro FI, de Azevedo EP, Freitas CIA, Guzen FP.

Curr Neuropharmacol. 2021;19(10):1738-1759. doi: 10.2174/1570159X19666210421091734.

Multisite transcranial direct current stimulation associated with cognitive training in episodic memory and executive functions in individuals with Alzheimer's disease: a case report

Marchi LZ, Ferreira RGD, de Lima GNS, da Silva JAS, da Cruz DMC, Fernandez-Calvo B, Andrade SMMDS.

J Med Case Rep. 2021 Apr 22;15(1):185. doi: 10.1186/s13256-021-02800-x.

Curcumin: A small molecule with big functionality against amyloid aggregation in neurodegenerative diseases and type 2 diabetes

Radbakhsh S, Barreto GE, Bland AR, Sahebkar A.

Biofactors. 2021 Jul;47(4):570-586. doi: 10.1002/biof.1735. Epub 2021 Apr 24.

A patent review of glutaminyl cyclase inhibitors (2004-present)

Coimbra JRM, Salvador JAR.

Expert Opin Ther Pat. 2021 Sep;31(9):809-836. doi: 10.1080/13543776.2021.1917549. Epub 2021 Jul 5.

Protective Effects of Nicotinamide Adenine Dinucleotide and Related Precursors in Alzheimer's Disease: A Systematic Review of Preclinical Studies

Hosseini L, Mahmoudi J, Pashazadeh F, Salehi-Pourmehr H, Sadigh-Eteghad S.

J Mol Neurosci. 2021 Jul;71(7):1425-1435. doi: 10.1007/s12031-021-01842-6. Epub 2021 Apr 28.

Inhibition of MK2 kinase as a potential therapeutic target to control neuroinflammation in Alzheimer's disease

Srivastava S, Rajopadhye R, Dey M, Singh RK.

Expert Opin Ther Targets. 2021 Apr;25(4):243-247. doi: 10.1080/14728222.2021.1924151. Epub 2021 May 10.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias